World's Best Scientists 2026 revealed!
Roland E. Kontermann

Roland E. Kontermann

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
15119
World Ranking
9153
National Ranking
663

Roland E. Kontermann publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Roland E. Kontermann sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 213 publications — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Roland E. Kontermann D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Roland E. Kontermann sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 65 D-Index — 55th percentile

55% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Roland E. Kontermann is affiliated with the University of Stuttgart in Germany and has contributed extensively to the fields of medicine and biochemistry, genetics, and molecular biology. Their research spans multiple subfields including molecular biology, radiology, nuclear medicine and imaging, oncology, immunology, and biomedical engineering.

The scientist's primary research topics include monoclonal and polyclonal antibodies, CAR-T cell therapy, glycosylation and glycoproteins, nanofabrication and lithography techniques, neuroinflammation and neurodegeneration mechanisms, cell death mechanisms and regulation, and peptidase inhibition and analysis.

Notable recent papers authored or co-authored by Roland E. Kontermann include:

  • The present and future of bispecific antibodies for cancer therapy (2024, Nature Reviews Drug Discovery)
  • Selective Targeting of TNF Receptors as a Novel Therapeutic Approach (2020, Frontiers in Cell and Developmental Biology)
  • TNF-Receptor-1 inhibition reduces liver steatosis, hepatocellular injury and fibrosis in NAFLD mice (2020, Cell Death and Disease)
  • Bispecific antibodies (2021, Science)
  • OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models (2020, Clinical Cancer Research)

Roland E. Kontermann collaborates frequently with other researchers. The most frequent co-authors include Oliver Seifert, Klaus Pfizenmaier, Roman Fischer, Nadine Aschmoneit, and Lennart Kühl.

Their work has been published in a variety of venues, with the most common publication outlets being mAbs, Journal of Neuroinflammation, Scientific Reports, Cancer Research, and Cell Death and Disease.

Best Publications

  • Isolation of high affinity human antibodies directly from large synthetic repertoires.

    A D Griffiths;S C Williams;O Hartley;I M Tomlinson

  • The making of bispecific antibodies

    Ulrich Brinkmann;Roland E. Kontermann

  • Strategies for extended serum half-life of protein therapeutics

    Roland E Kontermann

  • Dual targeting strategies with bispecific antibodies

    Roland E Kontermann

  • Recombinant bispecific antibodies for cancer therapy

    Roland E Kontermann

  • Improved Pharmacokinetics of Recombinant Bispecific Antibody Molecules by Fusion to Human Serum Albumin

    Dafne Müller;Anette Karle;Bettina Meissburger;Ines Höfig

  • Strategies to Extend Plasma Half-Lives of Recombinant Antibodies

    Roland E. Kontermann

  • Bispecific antibodies for cancer immunotherapy: Current perspectives.

    Dafne Müller;Roland E. Kontermann

  • Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105).

    Tina Völkel;Peter Hölig;Thomas Merdan;Rolf Müller

  • Half-life extended biotherapeutics

    Roland E Kontermann

  • A novel tri-functional antibody fusion protein with improved pharmacokinetic properties generated by fusing a bispecific single-chain diabody with an albumin-binding domain from streptococcal protein G.

    Roland Stork;Dafne Müller;Roland E. Kontermann

  • Recombinant single-chain Fv fragments carrying C-terminal cysteine residues: production of bivalent and biotinylated miniantibodies.

    Sergey M. Kipriyanov;Stefan Dübel;Frank Breitling;Roland E. Kontermann

  • Generation of angiostatin-like fragments from plasminogen by prostate-specific antigen

    H. H. Heidtmann;Dirk M. Nettelbeck;A. Mingels;R. Jäger

  • Specific gene transfer to neurons, endothelial cells and hematopoietic progenitors with lentiviral vectors

    Brigitte Anliker;Tobias Abel;Sabrina Kneissl;Juraj Hlavaty

  • Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells

    Peter Hölig;Miriam Bach;Tina Völkel;Thomas Nahde

  • Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

    Dirk M. Nettelbeck;Daniel W. Miller;Valérie Jérôme;Marylou Zuzarte

  • Selective Targeting of TNF Receptors as a Novel Therapeutic Approach

    Roman Fischer;Roland E Kontermann;Klaus Pfizenmaier

  • Bifunctional and multimeric complexes of streptavidin fused to single chain antibodies (scFv)

    S. Dübel;F. Breitling;R. Kontermann;T.G. Schmidt

  • Novel tetravalent and bispecific IgG-like antibody molecules combining single-chain diabodies with the immunoglobulin γ1 Fc or CH3 region

    Margitta Alt;Rolf Müller;Roland E Kontermann

  • A strategy of exon shuffling for making large peptide repertoires displayed on filamentous bacteriophage.

    Igor Fisch;Roland E. Kontermann;Ricarda Finnern;Oliver Hartley

Frequent Co-Authors

Klaus Pfizenmaier
Klaus Pfizenmaier University of Stuttgart
Rolf Müller
Rolf Müller Saarland University
Peter Scheurich
Peter Scheurich University of Stuttgart
Stefan Dübel
Stefan Dübel Technische Universität Braunschweig
Ekkehard K. F. Bautz
Ekkehard K. F. Bautz Heidelberg University
Andreas Herrmann
Andreas Herrmann RWTH Aachen University
Andreas Herrmann
Andreas Herrmann Humboldt-Universität zu Berlin
John R. Bethea
John R. Bethea George Washington University
Ugur Sahin
Ugur Sahin Johannes Gutenberg University of Mainz
Ulrich Brinkmann
Ulrich Brinkmann Roche (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're passionate about Biology and Biochemistry, there are numerous online degree options that can expand your expertise and career opportunities in healthcare, nutrition, and research. For those interested in human health and diet, earning an online nutrition degree provides a strong foundation for roles in wellness, public health, and clinical nutrition.

Advancing into healthcare management is also possible through specialized degrees. Aspiring leaders can pursue cahme-accredited online mha programs that focus on healthcare administration and organizational skills. For nurses hoping to reach the highest clinical and leadership levels, pursuing a dnp online no clinicals pathway is ideal for those seeking flexibility without direct clinical components.

Finally, professionals looking to make an impact on healthcare policy or executive roles should consider online doctoral programs healthcare administration. Each of these online degrees can complement a background in Biology or Biochemistry, opening doors to research, healthcare innovation, and leadership positions.

Best Scientists Citing Roland E. Kontermann

Trending Scientists

Recently Published Articles